A recent Brazilian study suggests that fish oil may play a key role in reducing insulin resistance and improving glucose tolerance, offering hope for non-obese individuals with type 2 diabetes.
A groundbreaking Brazilian study has revealed that fish oil supplementation could potentially reverse insulin resistance, particularly in non-obese individuals. The study, published in Nutrients, sheds new light on the relationship between omega-3 fatty acids and insulin resistance, offering hope for the 10%–20% of the global population with non-obese type 2 diabetes.
This preclinical research, funded by FAPESP, was conducted on Goto-Kakizaki (GK) rats, a model for non-obese type 2 diabetes. For eight weeks, rats were administered 2 grams of fish oil per kilogram of body weight, containing 540 mg/g of eicosapentaenoic acid (EPA) and 100 mg/g of docosahexaenoic acid (DHA). The results showed a remarkable reduction in insulin resistance, accompanied by improved blood sugar levels, lipid profiles, and inflammatory markers.
Omega-3 fatty acids have long been recognized for their cardiovascular benefits, but their impact on insulin resistance in non-obese individuals was poorly understood. This study is the first to demonstrate that fish oil supplementation can modulate immune cells—particularly lymphocytes—by shifting them from a pro-inflammatory to an anti-inflammatory state, thereby reversing insulin resistance.
Rui Curi, director of the Butantan Institute and coordinator of the study, explained that the findings suggest a potential link between inflammation and insulin resistance, even in the absence of obesity. The altered immune response seen in the GK rats parallels what is observed in obese individuals with insulin resistance, where immune cells like lymphocytes and macrophages produce pro-inflammatory cytokines.
The study further highlights the critical role of systemic inflammation in the development of insulin resistance. While obesity is a well-known risk factor, systemic inflammation in non-obese individuals may also contribute to the onset of type 2 diabetes. Curi suggests that the primary cause of insulin resistance in non-obese individuals could be genetic, and further research is necessary to explore the full range of factors contributing to the condition.
The study’s findings open new possibilities for treating non-obese type 2 diabetes patients, offering a potential therapeutic route that avoids the need for weight loss. This exciting research paves the way for further investigations into the impact of omega-3 fatty acids on diabetes and related metabolic conditions.
The researchers plan to continue studying the mechanisms behind insulin resistance in non-obese animals, expanding their understanding of how systemic inflammation influences diabetes. If future studies confirm the potential of fish oil in managing insulin resistance, it could revolutionize the way we treat diabetes and other inflammatory diseases.
U.S. and Pakistani leaders forecast a Sunday signing of a long-elusive framework agreement to end fighting between the United States and Iran, as Reut...
Tajikistan has strengthened its position as one of Central Asia’s fastest-growing economies. According to the European Bank for Reconstruction and D...
The New York Knicks defeated the San Antonio Spurs 94-90 to close out the series 4-1 and claim their first NBA championship since 1973, sparking celeb...
In the runup to the G7 summit, hosted by France in Évian-les-Bains on Monday, 15 June, China has addressed global economic balances in a videoconfer...
Switzerland on Sunday rejected a referendum proposal to cap its population at 10 million, a projection showed, as voters prioritised economic stabilit...
Australia has launched legal action against U.S. chemicals giant 3M, seeking more than $1.4 billion over contamination linked to firefighting foam containing PFAS chemicals, widely known as “forever chemicals”.
Britain’s King Charles III said on Friday, 12 December, that his cancer treatment is expected to be reduced in the coming year, using a televised address to urge people across the country to take part in cancer screening programmes, officials confirmed.
The European Union is reportedly considering banning the use of ethanol as an active ingredient in biocidal products — including hand sanitisers — due to rising concerns about potential cancer risks, the Financial Times reported on Tuesday.
Scientists in Australia and the U.S. have developed an AI tool that could transform cancer care by revealing the hidden diversity of tumour cells and guiding more targeted therapies.
Pakistan has warned that any attempt by India to block or significantly reduce river flows under the Indus Waters Treaty could have “far-reaching consequences”, after India's water minister said New Delhi was working to ensure that “not a single drop” of water reaches Pakistan in the coming years.
SpaceX made a historic entrance into the Nasdaq on Friday, surging over 20% in its first day of trading and lifting its valuation to more than $2 trillion. Investors flocked to the world’s largest IPO, betting on Elon Musk’s sprawling empire spanning rockets, AI and beyond.
Armenia has every right to choose Europe. But Europe’s support for Armenia’s direction should not become automatic approval of its political process.
U.S. President Donald Trump has said a peace agreement with Iran is scheduled to be signed on Sunday in a post on social media, despite Tehran's Foreign Ministry spokesperson Esmaeil Baghaei saying no deal would be approved this weekend.
Japan’s birth rate and fertility levels have fallen to their lowest levels on record, highlighting the country’s worsening demographic crisis as fewer people marry and have children.
A U.S. doctor who contracted Ebola while on a humanitarian mission in the Democratic Republic of Congo has recovered and been discharged from a hospital in Germany, according to officials.
Protesters in Nanyuki blocked roads and burned tyres after residents challenged a U.S. plan to house Americans exposed to Ebola at a nearby military base.
Global health organisation CEPI will provide around $60 million to Moderna and two other partners to speed up the development of vaccines targeting the Ebola Bundibugyo strain, which is currently driving an outbreak in eastern Democratic Republic of Congo.
The head of the World Health Organization (WHO) has warned that the Ebola outbreak in the Democratic Republic of Congo may be significantly larger than official figures suggest, following a visit to the country where he briefed President Felix Tshisekedi on the ongoing response.
Four nurses have recovered and been discharged after receiving treatment for Ebola in the Democratic Republic of Congo, the World Health Organisation (WHO) said.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment